References
Au WY, Lie AK, Kung AW, Mak W, Kwong YL (2005) Thyrotoxic periodic paralysis after allogeneic haematopoietic stem cell transplantation. Br J Haematol 129(1):160–161
Berger C, Le-Gallo B, Donadieu J, Richard O, Devergie A, Galambrun C et al (2005) Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant 35(10):991–995
Au WY, Lie AK, Kung AW, Liang R, Hawkins BR, Kwong YL (2005) Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation. Bone Marrow Transplant 35(4):383–386
Bartalena L, Wiersinga WM, Pinchera A (2004) Graves’ ophthalmopathy: state of the art and perspectives. J Endocrinol Investig 27(3):295–301
Ludgate M, Baker G (2004) Inducing Graves’ ophthalmopathy. J Endocrinol Investig 27(3):211–215
Hon C, Kwok AK, Shek TW, Ho WK, Ng WM, Lie AK et al (2003) Fibrous dysplasia masquerading as extramedullary relapse after bone marrow transplantation for chronic myeloid leukemia. Leuk Lymphoma 44(10):1823–1825
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hon, C., Yau, K., Chan, E.Y.T. et al. Graves’ ophthalmopathy after allogeneic stem cell transplantation. Ann Hematol 85, 887–888 (2006). https://doi.org/10.1007/s00277-006-0183-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-006-0183-4